A person living with Alzheimers disease uses a phone to speak to an AI chatbot called 'Livanna', at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

A person living with Alzheimers disease uses a phone to speak to an AI chatbot called 'Livanna', at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

This photograph shows drawings on a board at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

A resident attends a session with robots, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A carer programmes a robot named Nao (L) before a session with resident, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

Carer and residents attend a session with robots, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

This photograph shows the hand of a robot named Miroki during a session with residents, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A woman (L) living with Alzheimers disease uses a phone to speak to an AI chatbot called 'Livanna', at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)